Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study

Authors: Josephine E. B. Taylor, Julian Surey, Jennifer MacLellan, Marie Francis, Ibrahim Abubakar, Helen R. Stagg

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

In the UK, hepatitis B virus (HBV) incidence is associated with migrants from particular high-burden countries and population groups deemed ‘hard-to-reach’ by standard healthcare services: the homeless, people who inject drugs and ex-prisoners. Currently, there is a national targeted HBV vaccine policy for such at-risk groups, but there is limited recent evidence about 1) the levels of vaccine uptake, 2) the factors associated with incomplete vaccination, and 3) reasons for incomplete vaccination.

Methods

A questionnaire capturing social and medical history, demographic factors and information about HBV vaccination status was completed by individuals deemed hard-to-reach due to socio-structural factors that criminalise, isolate and stigmatise who consented to participate in a randomised controlled trial of a peer intervention to promote engagement with hepatitis C services. The questionnaire also captured the reasons for incomplete vaccination. Descriptive, univariable and multivariable regression analyses were undertaken.

Results

Three hundred fourty six participants completed the questionnaire. 1) 52.3% (n = 181) reported full HBV vaccination. 2) Within a multivariable model adjusting for sociodemographic variables, the presence of one or two or more socio-structural factors that are included in the national targeted vaccination policy was associated with protection against incomplete HBV vaccination (51.7% vaccine coverage in those with one factor, odds ratio 0.43 [95% confidence interval 0.20–0.92]); 70.1% coverage with two or more factors, 0.19 [0.09–0.39]; overall p-value < 0.001). Being female was also associated with lower vaccine uptake (2.37 [1.24–4.57], 0.01). Examining the socio-structural factors individually, intravenous drug use was associated with protection against incomplete HBV vaccination. 3) The most common reasons declared for incomplete vaccination were never being offered the vaccine or not returning for further doses.

Conclusion

Within this study of HBV vaccination uptake among hard-to-reach population groups in London, UK, we document 52.3% coverage of the full vaccine course. Critically, although participants recommended for immunisation within national guidelines had an increased likelihood of receiving a complete vaccine course, we note surprisingly low coverage in the presence of the risk factors that are national indicators for vaccination. Public health bodies should make additional efforts to improve coverage in the hard-to-reach through improved vaccine delivery systems.

Trial registration

ISRCTN24707359, Registered 19th October 2012.
Appendix
Available only for authorised users
Literature
3.
go back to reference Public Health England. Acute hepatitis B (England): annual report for 2017, vol. 12; 2017. Public Health England. Acute hepatitis B (England): annual report for 2017, vol. 12; 2017.
4.
go back to reference Ahmed F, Foster GR. Global hepatitis, migration and its impact on Western healthcare. Gut. 2010;59:1009–11.CrossRefPubMed Ahmed F, Foster GR. Global hepatitis, migration and its impact on Western healthcare. Gut. 2010;59:1009–11.CrossRefPubMed
9.
go back to reference Aldridge RW, Hayward AC, Hemming S, et al. High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population. Thorax. 2018;73:557–64.CrossRefPubMedPubMedCentral Aldridge RW, Hayward AC, Hemming S, et al. High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population. Thorax. 2018;73:557–64.CrossRefPubMedPubMedCentral
10.
12.
go back to reference Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, Constantine NT. Prevalence of human immunodeficiency virus, hepatitis b, and hepatitis c among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44:293–302.CrossRefPubMed Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, Constantine NT. Prevalence of human immunodeficiency virus, hepatitis b, and hepatitis c among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry. 2003;44:293–302.CrossRefPubMed
24.
go back to reference McGregor J, Marks PJ, Hayward A, Bell Y, Slack RCB. Factors influencing hepatitis B vaccine uptake in injecting drug users. J Public Health Med. 2003;25:165–70.CrossRefPubMed McGregor J, Marks PJ, Hayward A, Bell Y, Slack RCB. Factors influencing hepatitis B vaccine uptake in injecting drug users. J Public Health Med. 2003;25:165–70.CrossRefPubMed
25.
go back to reference Lamagni TL, Davison KL, Hope VD, Luutu JW, Newham JA, Parry JV, Gill ON. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health. 1999;2:174–7.PubMed Lamagni TL, Davison KL, Hope VD, Luutu JW, Newham JA, Parry JV, Gill ON. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health. 1999;2:174–7.PubMed
26.
28.
go back to reference Beck CR, Cloke R, O’Moore É, Puleston R. Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study. Vaccine. 2012;30:1965–71.CrossRefPubMed Beck CR, Cloke R, O’Moore É, Puleston R. Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study. Vaccine. 2012;30:1965–71.CrossRefPubMed
29.
go back to reference Gilbert RL, Costella A, Piper M, Gill ON. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Commun Dis Public Health. 2004;7:306–11.PubMed Gilbert RL, Costella A, Piper M, Gill ON. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Commun Dis Public Health. 2004;7:306–11.PubMed
30.
go back to reference Mahto M, Zia S. Measuring the gap: from Home Office to the National Health Service in the provision of a one-stop shop sexual health service in a female prison in the UK. Int J of STD AIDS. 2008;19:586–9.CrossRef Mahto M, Zia S. Measuring the gap: from Home Office to the National Health Service in the provision of a one-stop shop sexual health service in a female prison in the UK. Int J of STD AIDS. 2008;19:586–9.CrossRef
31.
go back to reference Plugge EH, Yudkin PL, Douglas N. Predictors of hepatitis B vaccination in women prisoners in two prisons in England. J Public Health Med. 2007;29:429–33.CrossRef Plugge EH, Yudkin PL, Douglas N. Predictors of hepatitis B vaccination in women prisoners in two prisons in England. J Public Health Med. 2007;29:429–33.CrossRef
32.
go back to reference Hutchinson SJ, Wadd S, Taylor A, Bird SM, Mitchell A, Morrison DS, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine. 2004;23:210–4.CrossRefPubMed Hutchinson SJ, Wadd S, Taylor A, Bird SM, Mitchell A, Morrison DS, et al. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine. 2004;23:210–4.CrossRefPubMed
Metadata
Title
Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study
Authors
Josephine E. B. Taylor
Julian Surey
Jennifer MacLellan
Marie Francis
Ibrahim Abubakar
Helen R. Stagg
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-3926-2

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.